United States Biotechnology & Medical Research

Zyla Life Sciences (ZCOR)

Track

Track

Ticker: ZCOR Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Shea Patrick M Chief Commercial Officer Officer
Transaction date
Planned sale
Price
131.53
Quantity 50,521 -48.9%
Value US$4,507,612
Strobeck Mark Chief Operating Officer
Transaction date
Planned sale
Price
1.29
Quantity 8,700 -41.9%
Value US$11,223
Shea Patrick M Chief Commercial Officer
Transaction date
Planned sale
Price
1.30
Quantity 910 -2.3%
Value US$1,183
Musial Stan Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.36
Quantity 3,480 -7.6%
Value US$8,213
Shea Patrick M Chief Commercial Officer Officer
Transaction date
Planned sale
Price
2.35
Quantity 910 -2.3%
Value US$2,138
VARKI PAUL SVP, GC & Chief Compliance Off Officer
Transaction date
Planned sale
Price
2.35
Quantity 806 -2.7%
Value US$1,894
Strobeck Mark Chief Operating Officer Officer
Transaction date
Planned sale
Price
2.39
Quantity 8,700 -29.5%
Value US$20,793
Musial Stan Chief Financial Officer
Transaction date
Planned sale
Price
5.04
Quantity 8,613 -15.8%
Value US$43,410
VARKI PAUL SVP, GC & Chief Compliance Off
Transaction date
Planned sale
Price
5.05
Quantity 806 -2.7%
Value US$4,070
Dayno Jeffrey M. Chief Medical Officer
Transaction date
Planned sale
Price
5.16
Quantity 536 -2.9%
Value US$2,766
Strobeck Mark Chief Operating Officer
Transaction date
Planned sale
Price
5.11
Quantity 8,700 -22.8%
Value US$44,457
Shea Patrick M Chief Commercial Officer
Transaction date
Planned sale
Price
4.75
Quantity 4,250 -10.0%
Value US$20,188
VARKI PAUL SVP, GC & Chief Compliance Off
Transaction date
Planned sale
Price
7.75
Quantity 806 -2.6%
Value US$6,246
Dayno Jeffrey M. Chief Medical Officer
Transaction date
Planned sale
Price
7.75
Quantity 536 -2.8%
Value US$4,154
Musial Stan Chief Financial Officer
Transaction date
Planned sale
Price
7.73
Quantity 13,480 -19.8%
Value US$104,200
Strobeck Mark Chief Operating Officer
Transaction date
Planned sale
Price
7.81
Quantity 8,700 -18.6%
Value US$67,947
VARKI PAUL SVP, GC & Chief Compliance Off Officer
Transaction date
Planned sale
Price
7.56
Quantity 806 -2.6%
Value US$6,093
Radie Robert S President and CEO Executive Director
Transaction date
Planned sale
Price
7.47
Quantity 15,000 -6.0%
Value US$112,050
Musial Stan Chief Financial Officer Officer
Transaction date
Planned sale
Price
7.47
Quantity 13,480 -16.5%
Value US$100,696
Strobeck Mark Chief Operating Officer Officer
Transaction date
Planned sale
Price
7.59
Quantity 25,000 -34.8%
Value US$189,750
Dayno Jeffrey M. Chief Medical Officer Officer
Transaction date
Planned sale
Price
7.69
Quantity 536 -2.7%
Value US$4,122
Strobeck Mark Chief Operating Officer Officer
Transaction date
Planned sale
Price
7.55
Quantity 8,700 -10.8%
Value US$65,685
Radie Robert S President and CEO Executive Director
Transaction date
Planned sale
Price
5.02
Quantity 5,000 -2.0%
Value US$25,100
Musial Stan Chief Financial Officer Officer
Transaction date
Planned sale
Price
5.05
Quantity 3,480 -4.1%
Value US$17,574
Radie Robert S President and CEO Executive Director
Transaction date
Planned sale
Price
4.94
Quantity 5,000 -1.9%
Value US$24,700
Musial Stan Chief Financial Officer Officer
Transaction date
Planned sale
Price
5.06
Quantity 10,000 -10.5%
Value US$50,600
Radie Robert S President and CEO Executive Director
Transaction date
Planned sale
Price
5.07
Quantity 5,000 -1.9%
Value US$25,350
Strobeck Mark Chief Business Officer Officer
Transaction date
Planned sale
Price
4.68
Quantity 8,700 -9.7%
Value US$40,716
Dayno Jeffrey M. Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.65
Quantity 536 -2.6%
Value US$2,492
Radie Robert S President and CEO Executive Director
Transaction date
Planned sale
Price
6.99
Quantity 5,000 -1.9%
Value US$34,950
Melloy Deanne F. Chief Commercial Officer Officer
Transaction date
Planned sale
Price
6.96
Quantity 860 -2.5%
Value US$5,986
Radie Robert S President and CEO Executive Director
Transaction date
Planned sale
Price
6.99
Quantity 5,000 -1.8%
Value US$34,950
Radie Robert S President and CEO Executive Director
Transaction date
Planned sale
Price
6.94
Quantity 5,000 -1.8%
Value US$34,700
Musial Stan Chief Financial Officer Officer
Transaction date
Planned sale
Price
7.02
Quantity 3,480 -3.5%
Value US$24,430
Dayno Jeffrey M. Chief Medical Officer Officer
Transaction date
Planned sale
Price
6.72
Quantity 536 -2.6%
Value US$3,602
Strobeck Mark Chief Business Officer Officer
Transaction date
Planned sale
Price
6.70
Quantity 8,700 -8.9%
Value US$58,290
Radie Robert S President and CEO Executive Director
Transaction date
Planned sale
Price
9.65
Quantity 3,000 -1.1%
Value US$28,950
Radie Robert S President and CEO Executive Director
Transaction date
Planned sale
Price
9.69
Quantity 4,000 -1.4%
Value US$38,760
Radie Robert S President and CEO Executive Director
Transaction date
Planned sale
Price
9.61
Quantity 3,000 -1.0%
Value US$28,830
Radie Robert S President and CEO Executive Director
Transaction date
Planned sale
Price
10.16
Quantity 2,100 -0.7%
Value US$21,336
Radie Robert S President and CEO Executive Director
Transaction date
Planned sale
Price
11.11
Quantity 1,400 -0.5%
Value US$15,554
Radie Robert S President and CEO Executive Director
Transaction date
Planned sale
Price
10.47
Quantity 1,500 -0.5%
Value US$15,705
Melloy Deanne F. Chief Commercial Officer Officer
Transaction date
Planned sale
Price
10.45
Quantity 860 -2.4%
Value US$8,987
Musial Stan Chief Financial Officer Officer
Transaction date
Planned sale
Price
10.68
Quantity 3,480 -3.4%
Value US$37,166
Dayno Jeffrey M. Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.40
Quantity 536 -2.5%
Value US$5,574
Strobeck Mark Chief Business Officer Officer
Transaction date
Planned sale
Price
10.40
Quantity 8,700 -8.2%
Value US$90,480
Index Venture Associates III Ltd Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 266,771 +36.0%
Value US$3,201,252
Index Venture Associates III Ltd Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 4,862 +23.1%
Value US$58,344
Index Venture Associates III Ltd Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 1,170 +8.2%
Value US$14,040
Index Venture Associates III Ltd Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 65,692 +8.2%
Value US$788,304
Danish Biotech SPV I P/S Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 83,333 +36.0%
Value US$999,996
Danish Biotech SPV I P/S Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 156,250 +8.4%
Value US$1,875,000
Index Venture Associates III Ltd Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 32,338 +8.2%
Value US$388,056
SEGERROS ANDREAS Rutger Non-Executive Director Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 133,333 +7.7%
Value US$1,599,996
FORMELA JEAN FRANCOIS Non-Executive Director Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 41,667 +2.0%
Value US$500,004
Atlas Venture Fund VII L P Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 41,667 +2.0%
Value US$500,004
AGUIAR-LUCANDER RENEE Non-Executive Director
Transaction date
Purchase
Price
12.00
Quantity 83,333 +36.0%
Value US$999,996
SUNSTONE LIFE SCIENCE VENTURES FUND II K/S Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 133,333 +7.7%
Value US$1,599,996
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-01-10 2019-12-30 S Sale
Riva Ridge Capital Management LP
3,651 -19.9%
446.95
US$854,027 		3,651 -19.9% 446.95 US$854,027
2020-01-10 2019-12-23 S Sale
Riva Ridge Capital Management LP
54,022 -1.6%
158.02
US$3,744,799 		54,022 -1.6% 158.02 US$3,744,799
2018-01-03 2018-01-02 PlS Planned sale Shea Patrick M

Chief Commercial Officer

Officer
50,521 -48.9%
131.53
US$4,507,612 		50,521 -48.9% 131.53 US$4,507,612
2017-10-03 2017-10-02 PlS Planned sale
Strobeck Mark

Chief Operating Officer
8,700 -41.9%
1.29
US$11,223 		8,700 -41.9% 1.29 US$11,223
2017-10-03 2017-10-02 PlS Planned sale
Shea Patrick M

Chief Commercial Officer
910 -2.3%
1.30
US$1,183 		910 -2.3% 1.30 US$1,183
2017-07-06 2017-07-03 PlS Planned sale Musial Stan

Chief Financial Officer

Officer
3,480 -7.6%
2.36
US$8,213 		3,480 -7.6% 2.36 US$8,213
2017-07-06 2017-07-03 PlS Planned sale
Shea Patrick M

Chief Commercial Officer

Officer
910 -2.3%
2.35
US$2,138 		910 -2.3% 2.35 US$2,138
2017-07-06 2017-07-03 PlS Planned sale
VARKI PAUL

SVP, GC & Chief Compliance Off

Officer
806 -2.7%
2.35
US$1,894 		806 -2.7% 2.35 US$1,894
2017-07-05 2017-06-30 PlS Planned sale
Strobeck Mark

Chief Operating Officer

Officer
8,700 -29.5%
2.39
US$20,793 		8,700 -29.5% 2.39 US$20,793
2017-04-05 2017-04-03 PlS Planned sale Musial Stan

Chief Financial Officer
8,613 -15.8%
5.04
US$43,410 		8,613 -15.8% 5.04 US$43,410
2017-04-04 2017-04-03 PlS Planned sale VARKI PAUL

SVP, GC & Chief Compliance Off
806 -2.7%
5.05
US$4,070 		806 -2.7% 5.05 US$4,070
2017-04-04 2017-03-31 PlS Planned sale Dayno Jeffrey M.

Chief Medical Officer
536 -2.9%
5.16
US$2,766 		536 -2.9% 5.16 US$2,766
2017-03-31 2017-03-31 PlS Planned sale Strobeck Mark

Chief Operating Officer
8,700 -22.8%
5.11
US$44,457 		8,700 -22.8% 5.11 US$44,457
2017-03-21 2017-03-20 PlS Planned sale Shea Patrick M

Chief Commercial Officer
4,250 -10.0%
4.75
US$20,188 		4,250 -10.0% 4.75 US$20,188
2017-01-04 2017-01-03 PlS Planned sale
VARKI PAUL

SVP, GC & Chief Compliance Off
806 -2.6%
7.75
US$6,246 		806 -2.6% 7.75 US$6,246
2017-01-04 2017-01-03 PlS Planned sale
Dayno Jeffrey M.

Chief Medical Officer
536 -2.8%
7.75
US$4,154 		536 -2.8% 7.75 US$4,154
2017-01-04 2017-01-03 PlS Planned sale
Musial Stan

Chief Financial Officer
13,480 -19.8%
7.73
US$104,200 		13,480 -19.8% 7.73 US$104,200
2017-01-04 2016-12-30 PlS Planned sale
Strobeck Mark

Chief Operating Officer
8,700 -18.6%
7.81
US$67,947 		8,700 -18.6% 7.81 US$67,947
2016-10-04 2016-10-03 PlS Planned sale
VARKI PAUL

SVP, GC & Chief Compliance Off

Officer
806 -2.6%
7.56
US$6,093 		806 -2.6% 7.56 US$6,093
2016-10-04 2016-10-03 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
15,000 -6.0%
7.47
US$112,050 		15,000 -6.0% 7.47 US$112,050
2016-10-04 2016-10-03 PlS Planned sale
Musial Stan

Chief Financial Officer

Officer
13,480 -16.5%
7.47
US$100,696 		13,480 -16.5% 7.47 US$100,696
2016-10-03 2016-09-30 PlS Planned sale Strobeck Mark

Chief Operating Officer

Officer
25,000 -34.8%
7.59
US$189,750 		25,000 -34.8% 7.59 US$189,750
2016-10-03 2016-09-30 PlS Planned sale Dayno Jeffrey M.

Chief Medical Officer

Officer
536 -2.7%
7.69
US$4,122 		536 -2.7% 7.69 US$4,122
2016-10-03 2016-09-30 PlS Planned sale
Strobeck Mark

Chief Operating Officer

Officer
8,700 -10.8%
7.55
US$65,685 		8,700 -10.8% 7.55 US$65,685
2016-07-06 2016-07-06 PlS Planned sale Radie Robert S

President and CEO

Executive Director
5,000 -2.0%
5.02
US$25,100 		5,000 -2.0% 5.02 US$25,100
2016-07-06 2016-07-05 PlS Planned sale Musial Stan

Chief Financial Officer

Officer
3,480 -4.1%
5.05
US$17,574 		3,480 -4.1% 5.05 US$17,574
2016-07-06 2016-07-05 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
5,000 -1.9%
4.94
US$24,700 		5,000 -1.9% 4.94 US$24,700
2016-07-06 2016-07-01 PlS Planned sale
Musial Stan

Chief Financial Officer

Officer
10,000 -10.5%
5.06
US$50,600 		10,000 -10.5% 5.06 US$50,600
2016-07-06 2016-07-01 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
5,000 -1.9%
5.07
US$25,350 		5,000 -1.9% 5.07 US$25,350
2016-07-05 2016-06-30 PlS Planned sale
Strobeck Mark

Chief Business Officer

Officer
8,700 -9.7%
4.68
US$40,716 		8,700 -9.7% 4.68 US$40,716
2016-07-05 2016-06-30 PlS Planned sale
Dayno Jeffrey M.

Chief Medical Officer

Officer
536 -2.6%
4.65
US$2,492 		536 -2.6% 4.65 US$2,492
2016-04-06 2016-04-05 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
5,000 -1.9%
6.99
US$34,950 		5,000 -1.9% 6.99 US$34,950
2016-04-06 2016-04-05 PlS Planned sale Melloy Deanne F.

Chief Commercial Officer

Officer
860 -2.5%
6.96
US$5,986 		860 -2.5% 6.96 US$5,986
2016-04-05 2016-04-04 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
5,000 -1.8%
6.99
US$34,950 		5,000 -1.8% 6.99 US$34,950
2016-04-05 2016-04-01 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
5,000 -1.8%
6.94
US$34,700 		5,000 -1.8% 6.94 US$34,700
2016-04-04 2016-04-01 PlS Planned sale
Musial Stan

Chief Financial Officer

Officer
3,480 -3.5%
7.02
US$24,430 		3,480 -3.5% 7.02 US$24,430
2016-04-04 2016-03-31 PlS Planned sale Dayno Jeffrey M.

Chief Medical Officer

Officer
536 -2.6%
6.72
US$3,602 		536 -2.6% 6.72 US$3,602
2016-04-04 2016-03-31 PlS Planned sale Strobeck Mark

Chief Business Officer

Officer
8,700 -8.9%
6.70
US$58,290 		8,700 -8.9% 6.70 US$58,290
2016-01-12 2016-01-11 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
3,000 -1.1%
9.65
US$28,950 		3,000 -1.1% 9.65 US$28,950
2016-01-12 2016-01-08 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
4,000 -1.4%
9.69
US$38,760 		4,000 -1.4% 9.69 US$38,760
2016-01-12 2016-01-07 PlS Planned sale Radie Robert S

President and CEO

Executive Director
3,000 -1.0%
9.61
US$28,830 		3,000 -1.0% 9.61 US$28,830
2016-01-07 2016-01-06 PlS Planned sale Radie Robert S

President and CEO

Executive Director
2,100 -0.7%
10.16
US$21,336 		2,100 -0.7% 10.16 US$21,336
2016-01-07 2016-01-05 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
1,400 -0.5%
11.11
US$15,554 		1,400 -0.5% 11.11 US$15,554
2016-01-07 2016-01-04 PlS Planned sale
Radie Robert S

President and CEO

Executive Director
1,500 -0.5%
10.47
US$15,705 		1,500 -0.5% 10.47 US$15,705
2016-01-05 2016-01-04 PlS Planned sale Melloy Deanne F.

Chief Commercial Officer

Officer
860 -2.4%
10.45
US$8,987 		860 -2.4% 10.45 US$8,987
2016-01-05 2016-01-04 PlS Planned sale Musial Stan

Chief Financial Officer

Officer
3,480 -3.4%
10.68
US$37,166 		3,480 -3.4% 10.68 US$37,166
2016-01-05 2015-12-31 PlS Planned sale
Dayno Jeffrey M.

Chief Medical Officer

Officer
536 -2.5%
10.40
US$5,574 		536 -2.5% 10.40 US$5,574
2016-01-05 2015-12-31 PlS Planned sale
Strobeck Mark

Chief Business Officer

Officer
8,700 -8.2%
10.40
US$90,480 		8,700 -8.2% 10.40 US$90,480
2014-02-13 2014-02-11 B Purchase Index Venture Associates III Ltd Large shareholder
266,771 +36.0%
12.00
US$3,201,252 		266,771 +36.0% 12.00 US$3,201,252
2014-02-13 2014-02-11 B Purchase Index Venture Associates III Ltd Large shareholder
4,862 +23.1%
12.00
US$58,344 		4,862 +23.1% 12.00 US$58,344
2014-02-13 2014-02-11 B Purchase Index Venture Associates III Ltd Large shareholder
1,170 +8.2%
12.00
US$14,040 		1,170 +8.2% 12.00 US$14,040
2014-02-13 2014-02-11 B Purchase Index Venture Associates III Ltd Large shareholder
65,692 +8.2%
12.00
US$788,304 		65,692 +8.2% 12.00 US$788,304
2014-02-13 2014-02-11 B Purchase Danish Biotech SPV I P/S Large shareholder
83,333 +36.0%
12.00
US$999,996 		83,333 +36.0% 12.00 US$999,996
2014-02-13 2014-02-11 B Purchase Danish Biotech SPV I P/S Large shareholder
156,250 +8.4%
12.00
US$1,875,000 		156,250 +8.4% 12.00 US$1,875,000
2014-02-13 2014-02-11 B Purchase Index Venture Associates III Ltd Large shareholder
32,338 +8.2%
12.00
US$388,056 		32,338 +8.2% 12.00 US$388,056
2014-02-12 2014-02-11 B Purchase SEGERROS ANDREAS Rutger Non-Executive Director Large shareholder
133,333 +7.7%
12.00
US$1,599,996 		133,333 +7.7% 12.00 US$1,599,996
2014-02-12 2014-02-11 B Purchase FORMELA JEAN FRANCOIS Non-Executive Director Large shareholder
41,667 +2.0%
12.00
US$500,004 		41,667 +2.0% 12.00 US$500,004
2014-02-12 2014-02-11 B Purchase Atlas Venture Fund VII L P Large shareholder
41,667 +2.0%
12.00
US$500,004 		41,667 +2.0% 12.00 US$500,004
2014-02-12 2014-02-11 B Purchase AGUIAR-LUCANDER RENEE Non-Executive Director
83,333 +36.0%
12.00
US$999,996 		83,333 +36.0% 12.00 US$999,996
2014-02-12 2014-02-11 B Purchase SUNSTONE LIFE SCIENCE VENTURES FUND II K/S Large shareholder
133,333 +7.7%
12.00
US$1,599,996 		133,333 +7.7% 12.00 US$1,599,996
Explore more

More insider trading research around Zyla Life Sciences

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America